3 Best Stocks to Buy Now, 7/2/2024, According to Top Analysts
Market News

3 Best Stocks to Buy Now, 7/2/2024, According to Top Analysts

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well. 

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio. 

Bitdeer Technologies (NASDAQ:BTDR) – Bitdeer Technologies operates as a technology company for blockchain and computing. Yesterday, Roth MKM analyst Darren Aftahi assigned a Buy rating on the stock with a price target of $14 per share. In the last three months, all six Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 33%. 

Chord Energy (NASDAQ:CHRD) – The company conducts exploration for crude oil, natural gas, and natural gas liquids. Yesterday, Citi analyst Paul Diamond initiated a Buy rating on the stock with a price target of $195. In the last three months, all ten Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 29%.

Penumbra (NYSE:PEN) – Penumbra is a medical device company. Yesterday, Deutsche Numis analyst Pito Chickering reiterated a Buy rating on the stock with a price target of $288 per share. Interestingly, five out of the six Top Analysts who recently rated the stock gave it a Buy. Taken together, their 12-month price targets imply an upside of about 48%. 

Who are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclosure 

Related Articles
TheFlyPenumbra’s CAVT technology shows benefits in pulmonary embolism
TheFlyPenumbra price target raised to $232 from $222 at RBC Capital
TheFlyPenumbra price target raised to $235 from $225 at Piper Sandler
Go Ad-Free with Our App